HIT Consultant September 4, 2025
After a few mixed years in medical technology (MedTech) mergers and acquisition (M&A) activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A transactions totaling $9.2 billion, compared to 62 deals worth $2.7 billion in Q1 2024, according to J.P. Morgan’s MedTech sector report.
First quarter venture capital (VC) funding was up as well, totaling $4.1 billion, the highest it has been since 2022. The number of confirmed transactions hit 216, reversing a four-quarter decline.
Several factors are contributing to this rise in activity. Post-pandemic economic recovery, an industry shift to building deep-domain offerings with product portfolios focused in certain therapeutic or specialty areas, an unusually conservative venture...
Today's Sponsors
Today's Sponsor